Discontinued — last reported Q3 '23

Non-Current Assets

Equity Method Investments

Raymond James Financial Equity Method Investments decreased by 18.6% to $131.00M in Q3 2025 compared to the prior quarter. Year-over-year, this metric declined by 18.6%, from $161.00M to $131.00M.

Analysis

StatementBalance Sheet Statement
SectionNon-Current Assets
CategoryCapital Allocation
SignalContext dependent
VolatilityModerate
First reportedQ4 2018
Last reportedQ3 2023

How to read this metric

An increase indicates strategic expansion through partnerships or joint ventures, while a decrease may signal divestments or impairment.

Detailed definition

These are investments in entities where the company exercises significant influence but does not have full control. The...

Peer comparison

Varies significantly based on corporate strategy; common in healthcare companies that partner with biotech startups or specialized diagnostic firms.

Metric ID: equity_method_investments

Historical Data

5 periods
 Q3 '21Q3 '22Q3 '23Q3 '24Q3 '25
Value$2.00M$343.00M$310.00M$161.00M$131.00M
QoQ Change—>999%-9.6%-48.1%-18.6%
YoY Change—>999%-9.6%-48.1%-18.6%
Range$2.00M – $343.00M
CAGR>999%
Avg YoY Growth>999%
Median YoY Growth-14.1%
Current Streak3 quarters decline

Frequently Asked Questions

What is Raymond James Financial's equity method investments?
Raymond James Financial (RJF) reported equity method investments of $131.00M in Q3 2025.
How has Raymond James Financial's equity method investments changed year-over-year?
Raymond James Financial's equity method investments decreased by 18.6% year-over-year, from $161.00M to $131.00M.
What does equity method investments mean?
The value of investments in other companies where the firm has significant influence but not total control.